Internal Medicine · Downey, CA
NPI
1336199660
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
11544 Downey Ave
Downey, CA, 90241
Phone (562) 922-2020
Groups this clinician bills Medicare through
Medicare paid, 2024
$674K
5,749 services
Medicare patients, 2024
545
Average age 74
Drug cost, 2024
$1.4M
16,977 prescriptions
Company payments, 2025
$168
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reza Sharafi was code 99233 (hospital e&m - subsequent), 1,172 times for 185 patients. In total Reza Sharafi billed 5,749 services in 54 codes, and Medicare paid $674K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 1,172 | 185 | $95.45 | $112K |
| 99349 Home E&M - New and Established | Office | 503 | 99 | $103.80 | $52K |
| 99309 SNF E&M | Facility | 315 | 103 | $88.57 | $28K |
| 99308 SNF E&M | Facility | 302 | 110 | $60.97 | $18K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 301 | 124 | $13.15 | $3,959 |
| 99215 Office E&M - Established | Office | 274 | 120 | $144.69 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 243 | 133 | $63.33 | $15K |
| 99223 Hospital E&M - Initial | Facility | 240 | 172 | $139.30 | $33K |
| 99306 SNF E&M | Facility | 239 | 144 | $148.29 | $35K |
| 99239 Hospital Discharge Management | Facility | 228 | 160 | $93.07 | $21K |
| 99348 Home E&M - New and Established | Office | 218 | 74 | $62.51 | $14K |
| 99310 SNF E&M | Facility | 212 | 95 | $126.07 | $27K |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 207 | 118 | $35.96 | $7,443 |
| 99214 Office E&M - Established | Office | 197 | 110 | $102.65 | $20K |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 134 | 36 | $24.48 | $3,280 |
By year: 2022 $363K for 3,872 services; 2023 $324K for 3,388 services; 2024 $674K for 5,749 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reza Sharafi prescribed most often to Medicare patients was Atorvastatin Calcium, with 945 prescriptions and refills. In total Reza Sharafi wrote 16,977 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 945 | 1,294 | 177 | $12K |
| Pantoprazole Sodium Generic | 626 | 782 | 117 | $9,812 |
| Amlodipine Besylate Generic | 597 | 845 | 121 | $3,655 |
| Gabapentin Generic | 590 | 729 | 100 | $8,369 |
| Eliquis Apixaban | 515 | 577 | 61 | $251K |
| Losartan Potassium Generic | 501 | 869 | 102 | $4,552 |
| Furosemide Generic | 496 | 619 | 81 | $2,958 |
| Levothyroxine Sodium Generic | 355 | 557 | 72 | $4,639 |
| Lisinopril Generic | 354 | 480 | 67 | $2,847 |
| Metformin Hcl Generic | 335 | 568 | 74 | $2,516 |
| Metoprolol Tartrate Generic | 334 | 410 | 52 | $2,483 |
| Potassium Chloride Generic | 334 | 411 | 59 | $5,230 |
| Carvedilol Generic | 322 | 479 | 68 | $2,925 |
| Tamsulosin Hcl Generic | 306 | 423 | 54 | $3,953 |
| Famotidine Generic | 301 | 322 | 52 | $2,668 |
Brand drugs: 2,375 claims; generic drugs: 14,244 claims; opioid claims: 310.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reza Sharafi $168 ($168 in general payments such as food, travel and fees) from 4 companies. The largest payer was Mannkind Corporation with $74.96.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.